向T辅助细胞17:克服移植排斥的新兴策略
Young Joon Lee1,2, Mi-La Cho1,2
1Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Clinical transplantation and research
|January 1, 2025
概括
辅助T17 (Th17) 细胞通过激活其他免疫细胞并促进炎症来驱动器官移植排斥. 抑制Th17细胞和平衡调节性T细胞 (Tregs) 的策略是实现移植耐受性的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 移植医学 移植医学
背景情况:
- 固体器官移植改善了末期器官衰竭的生存率.
- 异种移植的排斥仍然是一个主要的挑战,危及移植的成功.
- 辅助T细胞17 (Th17) 细胞是全移植体排斥的关键调解者.
研究的目的:
- 审查Th17细胞在异种移植细胞排斥中的多面性作用.
- 检查Th17细胞和其他T细胞子集之间的相互作用.
- 通过调节T细胞活性,探索诱导移植耐受性的治疗策略.
主要方法:
- 文献综述侧重于移植中的Th17细胞功能.
- 分析T细胞子集相互作用及其对排斥的影响.
- 评估当前和新兴的免疫抑制和诱导耐受性的策略.
主要成果:
- Th17细胞通过中性粒细胞的透和移植居民细胞的激活促进排斥.
- Th17细胞协调Th1,Th2和CD8+T细胞的激活.
- Th17细胞和调节性T细胞 (Tregs) 之间的不平衡加剧了排斥.
结论:
- 调节Th17细胞活性对于防止异种移植的排斥至关重要.
- 治疗策略包括免疫抑制和调节细胞 (Tregs,MDSCs) 的采用转移.
- 实现移植耐受性需要对T细胞调节采取全面的方法.
相关概念视频
Cell-mediated Immune Responses
66.8K
Overview
66.8K
Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
Tissue Transplantation
337
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
337
T Cell Types and Functions
946
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
946
T Cell Activation and Clonal Selection
651
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
651
Cytotoxic T Cells-mediated Immune Response
841
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
841


